Projects per year
Collaborations and top research areas from the last five years
Profiles
-
Development of Novel Small Molecules for Therapeutic Intervention in Pulmonary Arterial Hypertension (PAH)
Stockton, K. (Primary Chief Investigator (PCI)), Leach, K. (Chief Investigator (CI)), Stupple, P. (Chief Investigator (CI)), Bourke, J. (Chief Investigator (CI)), Mennen, G. (Chief Investigator (CI)), Shackleford, D. (Chief Investigator (CI)), Qin, C. H. (Chief Investigator (CI)) & Rahmani, R. (Partner Investigator (PI))
Department of Education (Australia), BioCurate Pty Ltd
19/03/26 → 18/03/27
Project: Research
-
EPTIC: EPTIC: Engineered peptides to target ion channels
Panyi, G. (Primary Chief Investigator (PCI)), Norton, R. (Chief Investigator (CI)), Wai, D. (Chief Investigator (CI)), Nicolazzo, J. (Chief Investigator (CI)), Herzig, V. (Chief Investigator (CI)), Szabó, I. (Chief Investigator (CI)), Varga, Z. (Chief Investigator (CI)), Papp, F. (Chief Investigator (CI)), Szanto, T. G. (Chief Investigator (CI)), Hajdu, P. (Chief Investigator (CI)), Zakany, F. (Chief Investigator (CI)), Naseem, M. U. (Chief Investigator (CI)) & Shakeel, K. (Chief Investigator (CI))
6/01/26 → 31/12/27
Project: Research
-
Fatty acid binding protein 5 at brain barriers: a contributor to motor neurone disease
Nicolazzo, J. (Primary Chief Investigator (PCI)), Oikari, L. (Chief Investigator (CI)), Rogers, M.-L. (Chief Investigator (CI)) & Keenan, R. (Chief Investigator (CI))
5/01/26 → 4/01/29
Project: Research
-
Correction to “Novel Scaffold Unlocks Potent Cross-Peptidase and Cross-Species Inhibitors as Promising Antimalarial Agents”
Mansouri, M., De Paoli, A., Giannangelo, C., Chowdury, M., Ngo, A., Shackleford, D. M., Webb, C. T., Lowes, K. N., Creek, D. J., Charman, S. A., De Koning-Ward, T. F., McGowan, S. & Scammells, P. J., 9 Apr 2026, In: Journal of Medicinal Chemistry. 69, 7, p. 8640 1 p.Research output: Contribution to journal › Comment / Debate › Other › peer-review
Open Access -
Increased ATP production and P-glycoprotein activity underlie the marked changes in blood–brain barrier transport of drugs in a mouse model of amyotrophic lateral sclerosis
Pan, Y., Spiteri, A. G., Runwal, P., Sun, J., Hutchinson, D. S., Kagawa, Y., Turner, B. J., Huang, C., Shah, A. D., Schittenhelm, R. B. & Nicolazzo, J. A., Jan 2026, In: British Journal of Pharmacology. 183, 2, p. 280-295 16 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access1 Link opens in a new tab Citation (Scopus) -
A novel chemoreactive calcilytic for the potential treatment of autosomal dominant hypocalcemia
Dangerfield, J., DeBono, A., Keller, A. N., Josephs, T. M., Shackleford, D. M., Gregory, K. J., Leach, K. & Capuano, B., Oct 2025, In: Acta Pharmaceutica Sinica B. 15, 10, p. 5387-5399 13 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access1 Link opens in a new tab Citation (Scopus)
Prizes
-
Australian Clinical Pharmacy Award
Elliott, R. (Recipient), 2018
Prize: Prize (including medals and awards)
-
Medicines for Malaria Venture (MMV) (External organisation)
Charman, S. A. (Inventor)
19 Jan 2016Activity: Industry, Government and Philanthropy Engagement and Partnerships › Patents › Patent
-
Medicines for Malaria Venture (MMV) (External organisation)
Charman, S. A. (Inventor)
18 Nov 2015Activity: Industry, Government and Philanthropy Engagement and Partnerships › Patents › Patent
-
Medicines for Malaria Venture (MMV) (External organisation)
Charman, S. (Inventor)
28 Jul 2015Activity: Industry, Government and Philanthropy Engagement and Partnerships › Patents › Patent